Dunne returns to the nation's largest school of nursing to advance student success and academic excellence
CHICAGO--(BUSINESS WIRE)-- Chamberlain University, a Covista institution and the nation's largest school of nursing, today announced Jason Dunne, DNP, MBA, MN, RN, as its next Chief Academic Officer, effective Sept. 14, 2026. Dunne will report to Amelia Manning, President, Chamberlain University, and will lead academic strategy, faculty development and curriculum across the university’s campuses and online programs nationwide, serving approximately 40,000 students.
Most recently, Dunne served as Chief Academic Officer at Arizona College of Nursing, where he provided academic leadership across more than 20 BSN campuses and helped lead the institution through significant growth, including the opening of 14 new campuses in four years. His work included academic quality, faculty development, accreditation and student outcomes. He also developed international nursing initiatives and partnerships in Canada, Jamaica and the Philippines, bringing a broad perspective on nursing education and health systems.
Before Arizona College of Nursing, Dunne spent six years at Chamberlain, first as Campus President of the Miramar campus from 2015 to 2020, then also as Campus President of the Jacksonville campus from 2018 to 2020, before becoming Senior Director of Campus Operations across the South Region. A registered nurse, Dunne began his career in clinical practice across community health, critical care, emergency and medical-surgical nursing before moving into academic and operational leadership, giving him firsthand experience across the full arc of the profession Chamberlain trains students to enter. He currently serves as President of the Nursing Consortium of Florida, where he has contributed to and supported the organization’s growth from a regional group to a statewide organization representing 80 member schools, colleges and health systems.
"Jason Dunne brings a combination of bedside experience and academic leadership at the highest level, and that shapes how he approaches nursing education," said Amelia Manning, President, Chamberlain University. "It gives him a perspective on student success that is not theoretical; it is earned. Chamberlain already sets the standard for nursing education at scale, and I have full confidence Jason is exactly the leader who will help us build on that position."
Dunne returns to Chamberlain at a moment of significant growth for the university with the commitment to launch 10 to 15 new campuses through fiscal year 2029. Dunne will help lead that growth into its next chapter, growing enrollment, strengthening persistence and advancing student outcomes as the university continues to expand.
"It's an honor to return to Chamberlain, a university with the national footprint and reputation to lead healthcare education forward," said Jason Dunne, Chief Academic Officer, Chamberlain University. "My focus is clear: build on the academic momentum already underway across our faculty and programs, and keep expanding access so more students, no matter where they start, can pursue or advance a career in healthcare."
Chamberlain offers pre-licensure and post-licensure nursing programs, a Master of Physician Assistant Studies (MPAS) program, and—through its College of Health Professions—a Master of Public Health (MPH) and a Master of Social Work (MSW).
Chamberlain University, a Covista institution, educates, empowers, and emboldens a community of healthcare professionals who seek to advance the health of people, families, communities, and nations. Grounded in Chamberlain Care®, Chamberlain has the largest school of nursing in the U.S., with both on-campus and online degree programs. Chamberlain is comprised of the College of Nursing and the College of Health Professions, offering a variety of bachelor's, master's, doctoral, and certificate programs. Chamberlain University is accredited by the Higher Learning Commission (https://www.hlcommission.org/). Visit chamberlain.edu for more information.
About Covista
Covista (NYSE: CVSA) is America's largest healthcare educator, serving 100,000 students and supported by a community of 400,000 alumni across five accredited institutions. Through personalized, tech-enabled education powered by 10,000 faculty and colleagues, Covista expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale. Covista is the parent company of American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. For more information, visit covista.com and follow us on LinkedIn, Instagram and YouTube.
*Applies to undergraduate students at campuses in AZ, FL, GA, IL, MO, OH, TX, VA, and IN.
A Bachelor of Science in Nursing (BSN) is a four‑year undergraduate degree that trains nurses in clinical care, leadership, and healthcare science. Investors monitor the proportion of BSN‑prepared nurses because higher levels of formal training often correlate with better patient outcomes, lower staff turnover and greater ability to handle complex care—factors that influence healthcare providers’ costs, reputation and regulatory risk.
accreditationregulatory
Accreditation is a formal recognition that an organization has met certain standards of quality and competence, similar to a certification of trustworthiness. It matters to investors because it indicates that the organization is properly evaluated and held to high standards, which can reduce risk and increase confidence in its operations or offerings.
pre-licensuretechnical
Pre-licensure describes the period when a product, usually a drug, vaccine, or medical device, is still in development and undergoing research, testing, and regulatory review before it can receive an official license or marketing approval. For investors it signals higher scientific and regulatory uncertainty—like a prototype still being tested before a safety certificate—because study results and regulator decisions will determine if and when the product can be sold.
post-licensuretechnical
Activities, studies and regulatory obligations that take place after a health product or medical technology has received official approval or a license to be sold. It covers safety monitoring, additional clinical or manufacturing studies, reporting of adverse events and any regulatory submissions tied to the approved product. Investors care because post-licensure work can change costs, supply, safety findings or legal exposure, similar to ongoing inspections and warranties after a product launch.
